Creative Planning Moderna, Inc. Call Options Transaction History

Creative Planning

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Jul 21, 2023	BUY	$118.5 - $160.53 $11,850 - $16,053	100 New	100 $12,000
Q3 2022 Nov 03, 2022	BUY	$118.07 - $194.18 $47,228 - $77,672	400 New	400 $13,000
Q1 2021 Apr 30, 2021	SELL	$109.18 - $185.98 $87,344 - $148,784	-800 Reduced 80.0%	200 $1,000
Q3 2020 Nov 05, 2020	BUY	$54.34 - $94.85 $21,736 - $37,940	400 Added 66.67%	1,000 $4,000
Q2 2020 Jul 23, 2020	BUY	$29.67 - $80.0 $17,802 - $48,000	600 New	600 $2,000

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.